We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 21-40 of 1,114 results
  1. Personalized and long-term electronic informed consent in clinical research: stakeholder views

    Background

    The landscape of clinical research has evolved over the past decade. With technological advances, the practice of using electronic informed...

    Evelien De Sutter, Pascal Borry, ... Isabelle Huys in BMC Medical Ethics
    Article Open access 31 July 2021
  2. Challenges and proposed solutions in making clinical research on COVID-19 ethical: a status quo analysis across German research ethics committees

    Background

    In the course of the COVID-19 pandemic, the biomedical research community’s attempt to focus the attention on fighting COVID-19, led to...

    Alice Faust, Anna Sierawska, ... Daniel Strech in BMC Medical Ethics
    Article Open access 19 July 2021
  3. The CORBEL matrix on informed consent in clinical studies: a multidisciplinary approach of Research Infrastructures Building Enduring Life-science Services

    Background

    Informed consent forms for clinical research are several and variable at international, national and local levels. According to the...

    Cinzia Colombo, Michaela Th. Mayrhofer, ... Paola Mosconi in BMC Medical Ethics
    Article Open access 17 July 2021
  4. Develo** a Framework for Self-regulatory Governance in Healthcare AI Research: Insights from South Korea

    This paper elucidates and rationalizes the ethical governance system for healthcare AI research, as outlined in the ‘Research Ethics Guidelines for...

    Junhewk Kim, So Yoon Kim, ... Hannah Kim in Asian Bioethics Review
    Article Open access 25 March 2024
  5. Unproven Stem Cell-Based Interventions: Addressing Patients’ Unmet Needs or Causing Patient Harms?

    Stem cells and regenerative medicine have been hyped over the past two decades as a cure for hundreds of diseases and disabilities. However, the...
    Chapter 2023
  6. Data privacy protection in scientific publications: process implementation at a pharmaceutical company

    Background

    Sharing anonymized/de-identified clinical trial data and publishing research outcomes in scientific journals, or presenting them at...

    Friedrich Maritsch, Ingeborg Cil, ... Borislava G. Pavlova in BMC Medical Ethics
    Article Open access 25 June 2022
  7. Rare Disease Research

    We address ethical issues in the field of rare diseases (RDs) focusing on four aspects that are relevant for research and translation into clinical...
    Francesc Palau, Carmen Ayuso in Handbook of Bioethical Decisions. Volume I
    Chapter 2023
  8. Assessment of the appropriateness of the i-CONSENT guidelines recommendations for improving understanding of the informed consent process in clinical studies

    Background

    The H2020 i-CONSENT project has developed a set of guidelines that offer ethical recommendations and practical tools aimed at making the...

    Jaime Fons-Martinez, Cristina Ferrer-Albero, Javier Diez-Domingo in BMC Medical Ethics
    Article Open access 13 October 2021
  9. Research Ethics and Research Ethics Committees in Europe

    In Europe, the topics of “research ethics” and “ethics committees” are becoming increasingly present in publications, university seminars, public...
    Chapter 2023
  10. Institutional Review Board (IRB): US Perspectives

    The institutional review board (IRB) is a federally mandated group instituted by the U.S. government to protect the rights and welfare of human...
    Maria I. Lapid, Yves Ouellette, ... Bart L. Clarke in Handbook of Bioethical Decisions. Volume II
    Chapter 2023
  11. Ethics and the marketing authorization of pharmaceuticals: what happens to ethical issues discovered post-trial and pre-marketing authorization?

    Background

    In the EU, clinical assessors, rapporteurs and the Committee for Medicinal Products for Human Use are obliged to assess the ethical aspects...

    Rosemarie D. L. C. Bernabe, Ghislaine J. M. W. van Thiel, ... Johannes J. M. van Delden in BMC Medical Ethics
    Article Open access 27 October 2020
  12. Boundaries Between Research, Surveillance and Monitored Emergency Use

    Responses to outbreaks, epidemics and pandemics involves a heterogeneous set of activities that aim to address threats to public health. In addition...
    Teck Chuan Voo, Ignacio Mastroleo in Research Ethics in Epidemics and Pandemics: A Casebook
    Chapter Open access 2024
  13. The Babel of Drugs: On the Consequences of Evidential Pluralism in Pharmaceutical Regulation and Regulatory Data Journeys

    Throughout the last century, pharmaceutical regulators all over the world have used various methods to test medical treatments. From 1962 until 2016,...
    Niccolò Tempini, David Teira in Data Journeys in the Sciences
    Chapter Open access 2020
  14. Regulatory, scientific, and ethical issues arising from institutional activity in one of the 90 Italian Research Ethics Committees

    Background

    This paper highlights the issues that one of the 90 Italian Research Ethics Committees (RECs) might encounter during the approval phase of...

    G. Benfatto, Laura Longo, ... F. Drago in BMC Medical Ethics
    Article Open access 07 April 2021
  15. Bioethical Decision-Making About Somatic Cell Genome Editing: Sickle-Cell Disease as a Case Study

    Somatic cell genome editing (SCGE) now allows exquisitely precise and targeted non-heritable changes to be made to human DNA. While SCGE has many...
    Christopher Rudge, Dianne Nicol in Handbook of Bioethical Decisions. Volume I
    Chapter 2023
  16. On the Normative Foundations of Pharmaceutical Regulation

    I argue that behind the 1962 Food and Drug Administration Act we find a combination of two normative principles: a liberal argument for the...
    Chapter 2020
  17. The Place of Digital and Artificial Intelligence in Medical Research

    Advances in the performance of computers and new algorithms now make it possible to manage and analyze faster and more data (big data, data sciences,...
    Chapter 2023
  18. Urban people’s preferences for life-sustaining treatment or artificial nutrition and hydration in advance decisions

    Background

    The Patient Right to Autonomy Act (PRAA), implemented in Taiwan in 2019, enables the creation of advance decisions (AD) through advance...

    Yi-Ling Wu, Tsai-Wen Lin, ... Sheng-Jean Huang in BMC Medical Ethics
    Article Open access 18 May 2024
  19. MAI: A Very Short History and the State of the Art

    This chapter gives a short overview of the history of MAI and describes its crucial contemporary applications. The aim is not to give a complete list...
    Giovanni Rubeis in Ethics of Medical AI
    Chapter 2024
  20. Therapeutic Genome Editing

    Efforts to cure single gene disorders by replacing the responsible genes using stem cell transplantation and gene transfer have been pursued for...
    Chapter 2023
Did you find what you were looking for? Share feedback.